AI cuts drug discovery from years to weeks, targeting a 10-15 year pipeline where 90% of candidates never reach market approval. Eli Lilly's tirzepatide franchise generated $36.5 billion in 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results